版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡(jiǎn)介
PrecociousPuberty
2024/1/12DiagnosisIntroductionTypesandCausesTreatment2024/1/12
PrecociousPuberty:
TheonsetofsecondarysexualcharacteristicsoccurringatanunusuallyearlyagePrecocious:
Girl:<8YBoy:<9Y
AmericanLawsonWilkinsPediatricEndocrineSociety
(LWPES):Whitegirl<7歲,Blackgirl<6歲Definition2024/1/12
Definition
PubertyisadevelopmentalprocessdefinedasthetransitionfromchildhoodtoadolescenceandadultreproductivefunctionManifestations:BreastenlargementinfemalesBeginningofmenstruationinfemalesGenitaliagrowthinmalesGrowthofpublichair
2024/1/12Tanner’sscale
ofbreastdevelopment2024/1/12BreastdevelopmentinfemaleStageI(Preadolescent)-OnlythepapillaiselevatedabovethelevelofthechestwallStageII-(BreastBudding)-ElevationofthebreastsandpapillamayoccurassmallmoundsalongwithsomeincreaseddiameteroftheareolaeStageIII-Thebreastsandareolaecontinuetoenlarge,althoughtheyshownoseparationofcontourStageIV-TheareolaeandpapillaeelevateabovethelevelofthebreastsandformsecondarymoundswithfurtherdevelopmentoftheoverallbreasttissueStageV-Maturefemalebreastshavedeveloped.ThepapillaemayextendslightlyabovethecontourofthebreastsastheresultoftherecessionoftheaerolaeTanner’sscale2024/1/12PubichairgrowthinfemalesStageI(Preadolescent)-Velloshairdevelopsoverthepubesinamannernotgreaterthanthatovertheanteriorwall.ThereisnosexualhairStageII-Sparse,long,pigmented,downyhair,whichisstraightoronlyslightlycurled,appears.ThesehairsareseenmainlyalongthelabiaStageIII-Considerablydarker,coarser,andcurliersexualhairappears.StageIV-Thehairdistributionisadultintypebutdecreasedintotalquantity.StageV-Hairisadultinquantityandtypeandappearstohaveaninversetriangleoftheclassicallyfemininetype.
Tanner’sscale2024/1/12PubichairgrowthinmalesStageI(Preadolescent)-Velloshairappearsoverthepubeswithadegreeofdevelopmentsimilartothatovertheabdominalwall.StageII-Thereissparsedevelopmentoflongpigmenteddownyhair,whichisonlyslightlycurledorstraight.Thehairisseenchieflyatthebaseofpenis.StageIII-Thepubichairisconsiderablydarker,coarser,andcurlier.ThedistributionisnowspreadoverthejunctionofthepubesStageIV-Thehairdistributionisnowadultintypebutstillisconsiderablylessthatseeninadults.ThereisnospreadtothemedialsurfaceofthethighsStageV-HairdistributionisadultinquantityandtypeandisdescribedintheinversetriangleTanner’sscale2024/1/12GenitaliadevelopmentinmaleStageI(Preadolescent)-Thetestes,scrotalsac,andpenishaveasizeandproportionsimilartothoseseeninearlychildhoodStageII-Thereisenlargementofthescrotumandtestesandachangeinthetextureofthescrotalskin.ThescrotalskinmayalsobereddenedStageIII-Furthergrowthofthepenishasoccurred,initiallyinlength,althoughwithsomeincreaseincircumference.Therealsoisincreasedgrowthofthetestesandscrotum.StageIV-Thepenisissignificantlyenlargedinlengthandcircumference,withfurtherdevelopmentoftheglanspenis.Thetestesandscrotumcontinuetoenlarge,andthereisdistinctdarkeningofthescrotalskin.StageV-Thegenitaliaareadultwithregardtosizeandshape.Tanner’sscale2024/1/12Praderorchidometer
G1:<3mlG2:4-8mlG3:10-15mlG4:15-20mlG5:25ml1,2,3;4,5,6,8;10,12;15,20;252024/1/12Epidemiology
Increasedincidence
4-5%ofgirlsfrombothracial(In1999)Female:Male=4~5:12024/1/12Epidemiology
12024/1/12Epidemiology
2024/1/12Epidemiology
2024/1/12BasicTerminologychronologicage:CAboneage:BAAssessmentofboneageisaclinicalprocedureusedinpediatricradiologytoevaluateskeletalmaturityonthebasisofbonegrowthinthelefthandandwrist,asseenonaradiograph.
2024/1/12BAofachild(8years)
9ossificationcenterswereshowninthepalmandwrist;spondylo-epiphysealwasn’tinafusionBAofAnadult
10ossificationcenterswereshowninthepalmandwrist;spondylo-epiphysealwasinafusionsesamoidbone
radialepiphysisulnaepiphysisProximalphalanxdistalphalanxmetacarpal2024/1/12Clinicalandsocialsignificance
1Induceearlybonematurationandreduceeventualadultheight2Indicatethepresenceofatumororotherseriousproblem3Causethechild,particularlyagirl,tobecomeanobjectofadultsexualinterest
2024/1/12DiagnosisIntroductionTypesandCausesTreatment2024/1/12Types13Partialprecociouspuberty2Peripheralprecociouspuberty(PPP)Centralprecociouspuberty(CPP)2024/1/12
1.Thecausecanbetracedtothehypothalamusorpituitary2.Gonadotropin-dependent3.Earlymaturationoftheentirehypothalamic-pituitary-gonadal(HPG)axis,withthefullspectrumofphysicalandhormonalchangesofpubertyCentralprecociouspuberty(CPP)2024/1/12hypothalamic-pituitary-gonadal(HPG)axis2024/1/122024/1/12CausesofCPPIdopathic—80-90%ingirlsOrganic—25-90%inboysTumor:Astrocytoma
,Opticnerveglioma,
Germcelltumors,Pinealtumors
、HamartomaOthers:CNS
damage(Trauma,radiation,infection
)Congenitalmalformations:arachnoidcyst,Asseptalabnormalities,hydrocephalus
2024/1/12Centralprecociouspubertyduetohypothalamichamartomainaoneyearandninemonth-oldboyRarecongenitalnonneoplasticheterotopiasThemostcommontumoralcauseofCPP
Mostoftheneuronsinahamartomaaresimilartonormalhypothalamicneurons●Diagnosis:thecharacteristiclocation,isointensitytonormalbrain,lackofcontrastenhancement,andabsenceofchangeinsizeandmorphologyofthemassatthefollow-up(MRIorCT).2024/1/12Generalinformation
◆1.8yroldboy◆
chiefcomplaint
abnormalenlargedexternalgenitaliaformorethan9months◆Historyofpresentillness
NoseizuresNoextrahormonesadmissionNootherabnormalsymptoms
2024/1/12Physicalexamination
Height:93cm
weight:17kg(>95percentile),genitalstageandpubichairstage:TannerstageII.testisvolume:10ml,penis:5cminlengthPhysicalexamination:nocoffeemacula,noSkinPigmentationandnoabnormalsigns.2024/1/122024/1/12LabtestsBaselineTestosterone416.0ng/dl(<20ng/dl)luteinizinghormone(LH)1.6mIU/ml(<0.4mIU/ml)folliclestimulatinghormone(FSH)2.1mIU/ml(1.8-12mIU/ml)prolactin(PRL)14.6ng/ml(4.3-13.7ng/ml)HCG<1mIU/ml17β-estradiol(E2)29.3pg/ml(<20pg/mL),progesterone(P)0.2ug/dlcortisol14.7ug/dl;ACTH30.0pg/ml17-alphahydroxyProgesterone(17a-OHP):1.35nmol/L2024/1/12luteinisinghormonereleasinghormone(LHRH)stimulationtest
peakLHlevels:21.7mU/ml
peakFSHlevels:3.8mU/mlTheratioofLH/FSH:5.7IGF-1:499.6ng/ml.ThyroidFunctionTest:normalBoneage-3-4yearsUltrasound:Noabnormalechogenicityonhistestisandadrenal
glands
2024/1/12Magneticresonanceimaging
Treatment----GnRHa(tillnow)2024/1/12Secondarysexualdevelopmentinducedbysexsteroidsfromotherabnormalsources2.Gonadotropin-independentPeripheralprecociouspuberty(PPP)
2024/1/12.Gonadaltumors.Adrenaltumors.Germcelltumor.Congenitaladrenalhyperplasia.McCune–AlbrightsyndromeExogenoushormones:EnvironmentalexogenoushormonesTreatmentforanotherconditionCausesofPPPEndogenoussources:Exogenoussources:2024/1/12McCune–AlbrightsyndromeZygoticmutationofthegeneGNAS1,whichisinvolvedinG-proteinsignallingPolyostoticfibrousdysplasiaSkinpigmentationAutonomousendocrinehyperfunction2024/1/12McCune–Albrightsyndrome2024/1/12
PrematurethelarchePrematureadrenarchePrematurepubarchePrematuremenarcheGynecomastiaPartialprecociouspuberty2024/1/12PrematurethelarcheAbenign,self-limitingconditionwhichischaracterisedbybreastdevelopmentNormalgrowthandboneageNoresponseofFSHandLHtoGnRHstimulationtest2024/1/12PrematureadrenarcheThemostcommoncauseoftheearlyappearanceofpubichair("prematurepubarche")DD:Congenitaladrenalhyperplasia,Androgen-producingtumorsoftheadrenalsorgonadsOccursmoreofteninchildrenwithintrauterinegrowthretardationandinoverweightchildren2024/1/12PrematurepubarcheTheprecociousappearanceofpubichair(P2)withoutothersignsofpubertyDD:CPP,nonclassicformsofcongenitaladrenalhyperplasia
2024/1/12Prematuremenarche
thefirstmenstrualcycle,orfirstmenstrualbleedingPartofpubertyIsolatedprematuremenarcheisrarelythefirstmanifestationofprecociouspuberty
2024/1/12GynecomastiaTheabnormaldevelopmentoflargemammaryglandsinmalesresultinginbreastenlargementThecauses:animbalanceofsexhormonesorthetissueresponsivenesstothem2024/1/12IntroductionDiagnosisTypesandCausesTreatment2024/1/12CPPdiagnosiscriteria
1.Earlyonsetofsecondarysexualcharacteristicsfemale<8Y,male<9Y2.Increasedbloodgonadotropinlevel:Baseline:LH>3.0~5.0IU/LGnRH
stimulationtest:GnRH2.5μg/kg(100μg/m2),iv,0,30,60mindrawblood,LH
peak>12IU/L(F),>25IU/L(M),LH/FSH>0.6~1.0(radioimmunoassay)LHpeak>3.3~5IU/L,LH/FSH>0.6(Chemiluminescence)2024/1/12CPPdiagnosiscriteria
3.Gonadenlargement:Ovarianvolume>1ml,d>4mmfollicle;4.Testicularvolume≥4ml,Progressiveincrease5.Acceleratedlineargrowth6.Boneage-actualage≥1Y7.Increasedbloodsexualhormones2024/1/12StepsofdiagnosisPhysicalexam—evaluateanychangesinthebody.Familyhistory—findoutifearlypubertymightruninthefamily.Bloodtests—hormonelevels.X-rays—boneage.MRIsofthebrain—ruleoutorganicCNScauses,liketumorsUltrasounds—oftheovaries,uterus2024/1/12Differentials
Peripheralprecociouspuberty
NoresponseofLHandFSHGnRH
stimulationtestPrematurethelarche
FSH↑↑,LH↑(<5IU/L),FSH/LH>1
GnRH
stimulationtestcanchangetoCPPFollowup2024/1/12DiagnosisIntroductionTypesandCausesTreatment2024/1/12ThegoaloftreatmentforCPPImprovetheeventualadultheightPreventmenarcheControlthedevelopmentofsecondsexualcharacteristicsPreventpsychosocialproblems2024/1/12GnRHanalogue(GnRHa)AsyntheticpeptidemodeledaftertheGnRH(Gonadotropin-releasinghormone)withspecificaminoacidsubstitutionstypicallyinposition6and10.Analoguewith2substitutions:leuprolide,buserelin,nafarelin,histrelin,goserelin,deslorelin2024/1/12HowitworksTheaminoacid
substitutionsinhibitrapiddegradation
DownregulationofGnRH-recepter
DecreasedreleaseofFSHandLH2024/1/12IndicationsToimproveadultheight:1)Boneage:female≤11.5,male≤12.5,Boneage-age>2(spondylo-epiphysealwasn’tinafusion)2)Predictedadultheight:female<150cm,male<160cm;3)Impairedgrowthpotential:Theheightofboneage<-2SDofnormalrange4)Improvementofboneage/improvementofage>12024/1/12DifferentPrepairationsPediatrics2009;123:e752–e7622024/1/12Administration
Dose:Firstdose:80~100μg/kg,repeatonceafter2w,then60~80μg/kg.q4W
Courseofthetreatment:≥2years(toimproveadultheight)
溫馨提示
- 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- 2024-2030年中國(guó)眼鏡行業(yè)市場(chǎng)發(fā)展分析及投資前景與策略研究報(bào)告
- 2024-2030年中國(guó)皮卡開(kāi)關(guān)行業(yè)市場(chǎng)發(fā)展趨勢(shì)與前景展望戰(zhàn)略研究報(bào)告
- 旅游景區(qū)在線預(yù)訂與營(yíng)銷推廣合同
- 旅游度假村設(shè)計(jì)與建設(shè)合同
- 2024-2030年中國(guó)電腦芯片行業(yè)市場(chǎng)深度調(diào)研及前景趨勢(shì)與投資前景研究報(bào)告
- 2024-2030年中國(guó)電熔氧化鋯制品市場(chǎng)供需格局與投資運(yùn)作模式分析研究報(bào)告
- 2024-2030年中國(guó)電子助力轉(zhuǎn)向行業(yè)市場(chǎng)發(fā)展趨勢(shì)與前景展望戰(zhàn)略研究報(bào)告
- 2024-2030年中國(guó)生活服務(wù)O2O模式發(fā)展分析及應(yīng)用案例與趨勢(shì)機(jī)會(huì)研究報(bào)告
- 2024-2030年中國(guó)玻璃激光劃線系統(tǒng)行業(yè)現(xiàn)狀態(tài)勢(shì)與競(jìng)爭(zhēng)趨勢(shì)預(yù)測(cè)報(bào)告
- 2024-2030年中國(guó)環(huán)己酮氰醇行業(yè)前景動(dòng)態(tài)及需求趨勢(shì)預(yù)測(cè)報(bào)告
- 基于視覺(jué)和慣性導(dǎo)航的水下機(jī)器人組合定位設(shè)計(jì)
- 門診理論知識(shí)培訓(xùn)
- 四年級(jí)上冊(cè)四則混合運(yùn)算練習(xí)400題及答案
- 護(hù)理專業(yè)大學(xué)生就業(yè)能力展示
- 尿道斷裂ppt課件教學(xué)查房
- “心肺復(fù)蘇指南”文件文集
- 《歐洲杯模板》課件
- 扶貧項(xiàng)目庫(kù)建設(shè)培訓(xùn)課件
- 《現(xiàn)代陶瓷藝術(shù)》課件
- 幼兒園二十四節(jié)氣課程教研方案
- 盤扣式腳手架培訓(xùn)課件
評(píng)論
0/150
提交評(píng)論